<img alt="" src="https://secure.lote1otto.com/219869.png" style="display:none;">
Skip to content

Post Market Commitments

Proving the effectiveness of a new therapy or biologic is essential to remaining competitive in a constantly evolving market.
 
Cytel’s ethos is to strategically prepare for post-market considerations while building a late phase data strategy. Our consultants and data management teams believe in preparing early and using all the evidence available to prepare you for success in a competitive market.

Communicating Value

Our specialists in clinical trial implementation work with our leading experts in health economics outcomes research (HEOR) to ensure your data is ready for cost-effectiveness modeling at the moment when FDA, EMA or other regulators gives it the greenlight. We can also prepare clinical datasets for those who have already received regulatory approval, and support submissions for Health Technology Assessments (HTA).

 Our experts are also well-versed in competitive effectiveness models, budget impact modeling, the preparation of global value dossiers, the creation of reimbursement dossiers, HEOR value communications and other elements of HEOR pricing strategy.

We help sponsors prepare data that is easily accessible to commercial teams to secure a strong return on investment, and provide insight into the dynamics of local and global markets. This enables sponsors to use their data to make the strategic case for driving commercial returns.

CYL2000_BrandGuide_R01v3-04

Power

Helping sponsors create an evidence-driven strategy for a competitive market.

CYL2000_BrandGuide_R01v3-04

Intelligence

Preparing sponsor commercial teams to make strategic use of clinical data.

CYL2000_BrandGuide_R01v3-04

Confidence

Clinical data management and advanced analytics for the delivery of valuable products.

Contact Us

Fill in the form below to get in touch